Clinical Trial Update: Using Transcranial Alternating Current Stimulation to Improve Executive Function in 22q11.2 Deletion Syndrome [NA]

View source ↗

Summary

A clinical trial is recruiting to evaluate whether transcranial alternating current stimulation (tACS) can improve executive function in individuals with 22q11.…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• 22q11 Deletion Syndrome

Drugs mentioned

• Transcranial Alternating Current Stimulation (transcranial alternating current stimulation)

Snippet

Sponsor: Stephan Eliez | Conditions: 22Q11 Deletion Syndrome, tACS | NA | Status: RECRUITING